Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Clinical trial NCT03844360 · RECRUITING

Trial details

NCT number: NCT03844360
Sponsor: Wei Zhao
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hematological Neoplasms

Start date: 2016-01-31
Primary completion: 2025-12-31
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.